Update on the Molecular Epidemiology and Diagnostic Tools for Blastocystis sp by Roberts, TJ et al.
Update on the Molecular Epidemiology and Diagnostic Tools for Blastocystis sp
Tamalee Roberts1,2*, Damien Stark1, John Harkness1 and John Ellis2
1Department of Microbiology, SydPath, St. Vincent’s Hospital, Victoria st, Darlinghurst, N.S.W, Australia
2School of Medical and Molecular Sciences, University of Technology, Sydney, Ultimo, N.S.W, Australia
*Corresponding author: Tamalee Roberts, Department of Microbiology, St. Vincent’s Hospital, Darlinghurst, N.S.W, Australia, Tel: 61283829209; Fax: 61283822989;
E-mail: troberts@stvincents.com.au
Rec Date: Jan 14, 2014, Acc date: Apr 24, 2014, Pub date: Apr 26, 2014
Copyright: © 2014 Robert T, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Blastocystis is the most common enteric protist found in humans. Due to the recent advancements in molecular
technologies, up to 17 subtypes have been identified from humans and animals. Molecular epidemiological studies
have shown the large range of subtype (ST) distribution within geographical locations with ST1-9 being identified in
humans. ST3 has been identified as the predominant subtype in most epidemiological studies with a considerable
absence of ST4 noted in Africa and the Middle East compared to Europe and Australia where this subtype is fairly
common. This review summarises the molecular tools used for diagnosis and speciation of Blastocystis and
comments on advancements in the area over the last 15 years and what future trends may be. This review also
describes the geographical distribution of Blastocystis and comments on possible intra-subtype evolutionary
relationships.
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Introduction
For a protist that was discovered over 100 years ago there is still so
much unknown about Blastocystis in regards to its pathogenicity,
transmission, lifecycle and susceptibility to antimicrobials. Symptoms
associated with Blastocystis infection include diarrhoea, abdominal
pains and bloating [1,2]. Until recently it was not possible to
differentiate between the subtypes of Blastocystis and many different
molecular techniques have been developed to distinguish between
them. In turn this has resulted in different terminologies being used
for the identification and designation of Blastocystis subtypes. So far
17 subtypes have been identified within the Blastocystis clades existing
in mammals, birds and reptiles. Due to recent studies it has been
shown that no group exclusive to humans exists and that human
isolates predominantly lie within subtype 1-4 [3-5]. Until recently, all
human isolates of Blastocystis were commonly referred to as
Blastocystis hominis and all other animal isolates were called
Blastocystis sp. but these recent molecular results now show that all
samples identified through only microscopy should be called
Blastocystis sp. due to there not being a single subtype specific to
humans. From many early studies completed on the subtyping of
Blastocystis, lack of consistency in the designation of subtypes resulted
in confusion and made it difficult for comparison and collaboration
within studies. A study on the consensus for the terminology of
Blastocystis compared all the previously published data which showed
many discrepancies with subtype allocation [6]. This paper proposed
that all isolates fall within nine subtypes and concluded that a
standardisation within the nomenclature would make future
epidemiological and clinical studies much easier. Since this paper was
published, a further eight subtypes have been identified from animals
[7-9]. Recently the whole genome sequence for subtype (ST) 7 was
completed. This new information has shed some light on many of the
aspects of Blastocystis including the metabolic pathways, virulence
factors and possible drug resistance mechanisms.
Typing Methods
Clark and colleagues were among the first to employ molecular
techniques to distinguish the various subtypes of Blastocystis present
in human stool samples. They used Restriction Fragment Length
Polymorphism (RFLP) analysis of Polymerase Chain Reaction (PCR)
amplified small subunit (SSU) rDNA for the rapid comparison of
multiple isolates. Through this technique they identified seven
different Blastocystis ribodemes, and suggested that Blastocystis was a
zoonosis [10]. In the last 15 years there has been extensive work done
in developing molecular techniques to distinguish the different
subtypes of Blastocystis and 17 subtypes have been identified from
humans and animals. Using PCR and RFLP analysis, which relies on
the digestion of PCR products with restriction endonucleases to yield
variable gel banding products, up to five different subtypes were
identified from different geographical locations [11-14]. The use of
RFLP can be problematic in that mixed infections may be missed and
if there is a mutation at any of the bases that make up the restriction
recognition sequence isolates could be incorrectly identified [15].
The application of subtype- specific primer pairs was developed to
distinguish between seven different subtypes but as more subtypes
have been identified this method for typing is not reliable as it does
not cover all the subtypes and therefore infections may be missed or
incorrectly assigned to a different subtype [16-18]. PCR with
subsequent dideoxy sequencing of amplified PCR products, targeting
typically the 18S SSU rRNA, is now the most common way for
identifying the different subtypes isolated from samples as this method
allows for all subtypes to be identified, given that correct primer pairs
have been chosen that do not show subtype preference [4].
Pyrosequencing technology combined with a nested PCR was
developed to differentiate between seven subtypes [15]. This system is
based on the pyrophosphate released when a nucleotide is introduced
to the DNA-strand and is suited for detecting single or multiple
nucleotide polymorphisms within short-read DNA sequences [19,20].
This technique shows a high specificity and sensitivity and is a fairly
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fast typing method. This technique does have problems though with
possible nucleotide miscalling in short reads and is also not possible to
discriminate between subtypes found in mixed infections.
There have only been three studies reported which have developed
a real-time (RT) PCR for Blastocystis. The first study [21] was able to
detect ST1, ST3 and ST4 but it is unknown whether other subtypes are
able to be detected using this assay and therefore the specificity and
sensitivity is unknown. The second study designed a genus- specific
PCR which was able to detect all known subtypes so far identified in
humans [22]. This test only had 95% specificity though, and the
amplicon size of 339 bp is much longer than usually desired for RT-
PCR sensitivity. The most recent study developed a TaqMan assay
which is highly sensitive and specific for subtypes 1-9 of Blastocystis
[23]. This appears to be the most sensitive and specific RT-PCR so far
developed but still does not differentiate between the subtypes. At the
moment it appears that RT-PCR could be the most useful tool for the
screening of Blastocystis but subtyping of isolates by conventional
PCR is still the only way to designate subtypes. The development of
RT- PCR techniques which have the ability to discriminate between
the different subtypes within a sample will be beneficial for screening
and epidemiological studies for Blastocystis. RT-PCR would also prove
to be more time and cost effective with extraction and RT-PCR
theoretically being able to be completed within only a few hours.
More recently Multilocus Sequence Typing (MLST) of the
Mitochondria-Like Organelle (MLO) of Blastocystis has been used to
show the differences in diversity within subtypes [24]. There were five
loci of ST3 MLST sequences studied and six loci for the ST4 MLST.
The authors showed that most human ST3 infections occur through
human- human transmission as most human infections were restricted
to a single clade (MLO clade 1) within the ST3 group. Animal
infections and people exposed to animals (in particular animal
handlers) were found to lie within three other clades which show the
result of zoonotic transmission. This study showed the intra-subtype
genetic variability within ST3 and ST4. The study also suggested that
ST4 has a more recent history of colonising humans than ST3 due to
the lack of variation within the sequences and also because ST4 is
common in European populations but is rarely found elsewhere.
The use of the “barcode region” for sequencing appears to be the
most effective for the designation of Blastocystis subtypes and is the
best technique used if phylogenetic information is to be obtained [4].
DNA barcoding refers to a method proposed to produce a unique
identifier for all living species and has been used previously to study a
variety of animals [25,26]. The Blastocystis barcode region amplifies
the 5’ 600 bp region of the Blastocystis SSU-rDNA using the primer
pair of RD5, a primer with broad eukaryotic specificity, and BhRDr
which is more specific to Blastocystis and was designed for subsequent
sequencing. This PCR does have the possibility for false positives
though if only used for Blastocystis screening. The PCR has the ability
to detect other eukaryotes particularly fungi which makes this
technique not desirable when sequencing of positives is not available.
A substantial number of sequences in Genbank use the “barcode
region” and have been submitted to the Blastocystis Subtype (18S) and
Sequence Typing (MLST) Database (www.pubmlst.org/blastocystis)
which makes comparison and designation of subtypes simpler and
keeps integrity within the subtype allocations. The advantage of the
Blastocystis Subtype (18S) and Sequence Typing (MLST) Database is
that it uses the consensus subtype nomenclature (discussed below),
unlike GenBank, and also assigns the allele to the SSU-rDNA barcode
sequence [27]. This database currently has 255 sequences and 64
MLST profiles and is continually updated.
The uses of matrix-assisted laser desorption/ionisation time-of-
flight mass spectrometry (MALDI-TOF MS) has recently
revolutionised the clinical microbiology laboratory with accurate,
rapid results available for the identification of microorganisms. A
recent study showed the accuracy of MALDI-TOF MS for the
speciation of five different Blastocystis STs [28]. Axenic cultures
speciated by SSU-rDNA analysis were used to create profiles for the
different Blastocystis subtypes. It was found that speciation was better
after extraction using the ethanol/formic acid procedure. Axenic
cultures were shown to be the preferred sample used with xenic broth
cultures not having as high ID scores. This study did have a small
study number though and showed the limitations of the xenic cultures.
This does however highlight an exciting area of research for the future
which could substantially cut costs for Blastocystis detection and
speciation.
Before 2007 there was not a standardised subtype nomenclature and
several studies assigned the same subtypes to different groups creating
some confusion and meaning an overall global picture of Blastocystis
molecular epidemiology was not possible. A consensus was agreed
upon in 2007 and since then a greater picture of subtype infection has
been possible [6]. Although there is now a standardised nomenclature,
there is still not a standardised method for subtyping with people
doing sequencing on different regions of the SSU rDNA or using
Sequence-Tagged-Site PCR for subtype designation. Through the
application of these different techniques it has been shown that there is
substantial antigenic and genetic heterogeneity among Blastocystis
isolates within and among geographical regions. Special care must be
taken when choosing the primers used in PCR where certain primers
can have an effect on the final result. Some primers have specific
subtype amplification preferential, which could result in other
subtypes being missed in the analysis. Also some primers have been
developed from cultured samples, whereas others work better with
direct extraction of DNA from the stool so this needs to be taken in to
consideration when using molecular techniques for diagnosis. The
primers that are being used may have different sensitivity depending
on what sort of sample is being used and may give an incorrect result.
There is still much more work needed to develop a simple and
effective method for the detection and typing of Blastocystis sp. A RT-
PCR that is able to detect and allocate all of the subtypes would be the
most useful for diagnosis as well as epidemiological studies whereas
the “barcode region” may be the most effective technique for
phylogenetic studies and showing evolutionary relationships.
Epidemiology
The prevalence of Blastocystis infection was stated as being higher
in developing countries than in developed countries [29]. Due to
varying modes of diagnostic techniques used in epidemiological
studies of Blastocystis, it is difficult to determine the actual prevalence
of Blastocystis due to some studies relying solely on microscopy for
diagnosis. It was shown that molecular techniques have the highest
sensitivity rates for diagnosis of this organism [30,31] and the use of
only microscopy in diagnosis and epidemiological studies limits
interpretation of data on prevalence of Blastocystis infections.
Through the use of molecular techniques for epidemiological
studies, ST3 was found to be the predominant subtype isolated in
humans with a range of 40-92% of isolates belonging to this group
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[10,13,32]. There have been two studies where ST1 was the
predominant subtype with 51.4% of positive from this group
belonging to this group in China, 41% in Brazil [17,33,34] and three
others where ST4 was the predominant subtype with 63% in France,
84% in Nepal and 94.1% in Spain, with no ST3 identified in the Spain
population [22,35,36]. From South American countries it is seen that
there is a predominance of ST1, ST2 and ST3 with no other STs being
isolated. ST1 appears to be the predominant ST from these South
American studies followed by ST2 then ST3 with no ST4 noted
[34,37].
In Singapore the prevalence of Blastocystis is at 3.3% of the studied
population with ST1 and ST3 being the only subtypes isolated. There
was a 78% incidence of ST3 and a 22% incidence of ST1. This
prevalence of ST3 in humans in an urbanised area such as Singapore is
consistent with the argument that ST3 is of human origin [38].
An investigation of isolates of Blastocystis in Japan, Pakistan,
Bangladesh, Germany and Thailand showed that ST3 was the most
common varying from 41.7-92.3% positives with the second most
common being ST1 (7.7-25%) and ST4 (10- 22.9%). In Bangladesh an
almost equal number of symptomatic and asymptomatic isolates were
tested but there was no major percentage difference between ST1 and
ST3 so it is not possible to comment on the pathogenicity of these two
subtypes [18].
The incidence of Blastocystis in a province in China showed 32.6%
of people studied were positive for Blastocystis. ST3 was the
predominant subtype in 70.5% of the positive population, followed by
ST1 with 20.5%. The significance of hygienic practices was shown to
have an effect on the type of infection with ST3 corresponding to the
drinking of unboiled water and ST1 relating to the consumption of
raw water plants [39].
In Lebanon there was a 19% incidence of Blastocystis from a
population of symptomatic and asymptomatic people [40]. Four
subtypes were identified with almost equal numbers of ST3 (33.3%),
ST2 (33.3%) and ST1 (30.6%) and only one patient with ST4 (2.8%).
There was an association seen between ST1 and symptoms.
A study performed to show the incidence of intestinal parasites
among immigrants in food handling and housemaid jobs in Qatar
showed that of the 1337 people surveyed from the Philippines,
Indonesia, Indian sub-continent and Africa over two years, there were
588 individuals positive for at least one of the parasites studied. Of all
the parasites studied, Blastocystis was shown to have the second
highest incidence rate at 13.2% for all the nationalities put together
with only a slightly higher incidence in African samples than the other
nationalities. There was a much higher incidence in women than men
[41].
A study of an aborigine community in Pahang, Malaysia showed
that Blastocystis had the highest incidence rate (52.3%) followed by G.
lamblia (29.2%). Overall there was a 72.3% positive parasitic infection
rate for this community. These high rates of parasitic infection can be
attributed to the low standard of sanitation and hygiene in this area
with there being no electricity, running water or toilets inside their
dwellings and water from the river being used for all purposes
including cooking, bathing, swimming and washing vegetables [42].
In a Zambian school, 53.8% of children were reported to be infected
with Blastocystis with some being co-infected with Endolimax nana
(which is another parasite not considered to be pathogenic to humans)
with almost half the children suffering from diarrhoea. This study
supports the argument that Blastocystis infections are associated with
inadequate sanitation and low hygienic standards and can contribute
to diarrhoea in children in developing countries [43].
For travellers, it was shown that there is an increased rate of
infection while travelling to tropical and under-developed countries,
with 30% infection rates found in tourists in Nepal. It is frequently
identified in stools from foreign workers in South-east Asia and
Taiwan, with the incidence of infection being attributed to poor
personal and environmental hygiene, lack of water supply and poor
sewage and rubbish removal [44]. For 36 Peace Corps volunteers
(PCV’s) in Guatemala for a length of two years or greater there was a
38.8% infection rate with an intestinal parasite. Blastocystis was the
most common parasite in these samples at 77.8% with a progressive
increase in infection from 11.1% of PCV’s at the start to 37.9% and
then 53.1% and then 77.8% at the end of the 2 year study. Most of the
Blastocystis infections were found to be asymptomatic and last several
weeks. The prevalence of intestinal parasites found in these PCV’s in
Guatemala could be attributed to them being repeatedly exposed to
potentially risky diets and diarrheal illness is the most common
medical disorder encountered by travellers from developed countries
to developing countries [45].
In an orphanage in Thailand over a one year period the rate of
infection varied between 6.6%- 27.4% with samples being taken every
two months [46]. These varying results could have been due to the
shedding effect seen in many cases of parasitic infection as well as the
diagnostic technique (microscopy of a permanent smear and culture)
being used not being sensitive enough. These results also highlight the
easy transmission of Blastocystis in places with poor hygiene. Table 1






Subtypes identified (%) References
1 2 3 4 5 6 7 8 9 unknown/ mixed
Australia (513) 91 28 5 40 12 0 6 1 2 0 0 [47]
Australia 12 41 0 33 16 0 8 0 0 0 8 [48]
Bangladesh 26 7.7 0 92.3 0 0 0 0 0 0 0 [18]
Brazil (382) 66 41 32 17 0 0 0 0 0 0 10 [34]
China, Yunnan (239) 78 20.5 1.3 70.5 1.3 0 0 0 0 0 5 [39]
Colombia 125 56 32 12 0 0 0 0 0 0 0 [37]
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Denmark 29 3.4 20.7 51.7 24.1 0 0 0 0 0 0 [49]
Denmark (126) 24 8.3 12.5 25 37.5 0 0 0 0 12.5 0 [50]
Denmark (444) 25 4 16 4 76 0 0 0 0 0 0 [51]
Egypt 44 18.2 0 54.5 0 0 18 9.1 0 0 0 [52]
Egypt 100 15 0 49 0 0 33 13 0 0 10 [53]
France 40 25.6 9.3 53.5 9.3 0 0 2.3 0 0 7.5 [32]
Germany (67) 12 25 0 41.7 0 17 0 17 0 0 0 [18]
Germany 171 23.4 0.6 69 7 0 0 0 0 0 3 [12]
Greece 45 20 13.3 60 2.2 0 2.2 2.2 0 0 0 [54]
Italy (34) 34 8.8 20.6 47.1 17.7 0 0 2.9 2.9 0 4 [55]
Iran 40 50 10 40 0 0 0 0 0 0 12 [56]
Iran 141 34 23 37 0 0 0 5 0 0 23 [57]
Japan 64 15.6 20.3 48.4 10.9 0 0 0 0 0 4.7 [13]
Japan (2,037) 50 8 0 52 4 0 22 10 0 4 0 [18]
Lebanon (220) 42 30.6 33.3 33.3 2.8 0 0 0 0 0 0 [40]
Liberia 25 28 28 32 12 0 0 0 0 0 20 [9]
Libya 38 50 7.9 39.5 0 0 0 2.6 0 0 0 [9]
Malaysia 40 12.5 5 50 27.5 0 0 0 0 0 2 [58]
Nepal (82) 20 20 20 60 0 0 0 0 0 0 0 [59]
Nepal (241) 63 63.5 12.7 0 84.1 0 0 0 0 0 70 [36]
Netherlands (442) 103 22 22 42 0 0 1 1 0 0 0 [60]
Nigeria 22 45.5 0 40.9 13.6 0 0 0 0 0 0.4 [9]
Pakistan 10 20 0 70 0 0 10 0 0 0 0 [18]
Philippines 5 20 0 80 0 0 0 0 0 0 0 [61]
Singapore (276) 9 22.2 0 77.8 0 0 0 0 0 0 0 [38]
Spain 51 2 3.9 0 94.1 0 0 0 0 0 0 [35]
Sweden 63 15.9 14.3 47.6 20.6 0 0 1.6 0 0 0 [62]
Thailand (30) 5 40 0 40 0 0 20 0 0 0 20 [18]
Thailand (675) 127 77.9 22.1 0 0 0 0 0 0 0 0 [63]
Turkey (286) 92 20 24 59.7 0 0 0 0 0 0 4 [64]
Turkey 87 9.2 13.8 75.9 1.1 0 0 0 0 0 0 [65]
Turkey 25 36 24 10 0 0 0 0 0 0 0 [66]
UK 55 5.4 16.4 40 31 0 0 1.8 5.4 0 0 [4]
UK 271 12.5 9.6 42.1 31.4 0.7 0.4 1.5 1.8 0 0 [9]
USA 21 11.1 0 66.7 0 0 0 0 0 0 22.2 [2]
Table 1: Subtype classification of human Blastocystis sp. isolates from different countries
Citation: Roberts T, Stark D,Harkness J, Ellis J (2014) Update on the Molecular Epidemiology and Diagnostic Tools for Blastocystis sp. J Med
Microb Diagn 3: 131. doi:10.4172/2161-0703.1000131
Page 4 of 6
J Med Microb Diagn
ISSN:2161-0703 JMMD, an open access journal Volume 3 • Issue 1 • 1000131
From all the epidemiological studies a pattern can be seen where
there is a much higher incidence of ST4 in Europe and Australia
compared to Africa, the Middle East and South America where very
low numbers, if any, are seen. Why this is occurring is unknown, but it
could be due to several reasons. The use of diagnostic tool may have an
effect on the STs identified, as previously discussed, with some primer
pairs showing ST preferential. Another reason may be due to the
recent evolution of ST4. There is a much higher homogeny among ST4
samples compared to ST3, which is the closest related ST from
phylogenetic studies, suggesting that this may be a relatively new ST
[24].
Conclusions
The future of Blastocystis diagnostics and epidemiology is an
exciting area. With the possibility of new genomes being available for
the different subtypes, this may help improve targets for RT-PCR that
will be beneficial for both diagnosis and differentiation between
subtypes. As diagnosis and speciation becomes easier, more
epidemiological studies will be possible which may potentially show
the large range of Blastocystis distribution around the world. As more
samples are studied, the relationship between geographical location
and subtype might become apparent as well as intra-subtype
evolutionary relationships.
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